Neil Josephson - Net Worth and Insider Trading

Neil Josephson Net Worth

The estimated net worth of Neil Josephson is at least $130,041 dollars as of 2024-05-03. Neil Josephson is the Chief Medical Officer of Zymeworks Inc and owns about 14,449 shares of Zymeworks Inc (ZYME) stock worth over $130,041. Details can be seen in Neil Josephson's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Neil Josephson has not made any transactions after 2022-11-10 and currently still holds the listed stock(s).

Transaction Summary of Neil Josephson

To

Neil Josephson Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Neil Josephson owns 1 companies in total, including Zymeworks Inc (ZYME) .

Click here to see the complete history of Neil Josephson’s form 4 insider trades.

Insider Ownership Summary of Neil Josephson

Ticker Comapny Transaction Date Type of Owner
ZYME Zymeworks Inc 2022-11-10 Chief Medical Officer

Neil Josephson Latest Holdings Summary

Neil Josephson currently owns a total of 1 stock. Neil Josephson owns 14,449 shares of Zymeworks Inc (ZYME) as of November 10, 2022, with a value of $130,041.

Latest Holdings of Neil Josephson

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ZYME Zymeworks Inc 2022-11-10 14,449 9.00 130,041

Holding Weightings of Neil Josephson


Neil Josephson Form 4 Trading Tracker

According to the SEC Form 4 filings, Neil Josephson has made a total of 4 transactions in Zymeworks Inc (ZYME) over the past 5 years, including 1 buys and 3 sells. The most-recent trade in Zymeworks Inc is the sale of 2,475 shares on November 10, 2022, which brought Neil Josephson around $20,048.

Insider Trading History of Neil Josephson

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Neil Josephson Trading Performance

GuruFocus tracks the stock performance after each of Neil Josephson's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Neil Josephson is -51.95%. GuruFocus also compares Neil Josephson's trading performance to market benchmark return within the same time period. The performance of stocks bought by Neil Josephson within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Neil Josephson's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Neil Josephson

Average Return

Average return per transaction

Outperforming Transactions

0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -43.59
Relative Return to S&P 500(%) -39.46

Neil Josephson Ownership Network

Ownership Network List of Neil Josephson

No Data

Ownership Network Relation of Neil Josephson


Neil Josephson Owned Company Details

What does Zymeworks Inc do?

Who are the key executives at Zymeworks Inc?

Neil Josephson is the Chief Medical Officer of Zymeworks Inc. Other key executives at Zymeworks Inc include director & Chair & CEO Kenneth Galbraith , SVP & Chief Financial Officer Christopher Astle , and Chief Scientific Officer Paul Andrew Moore .

Zymeworks Inc (ZYME) Insider Trades Summary

Over the past 18 months, Neil Josephson made 3 insider transaction in Zymeworks Inc (ZYME) with a net sale of 7,425. Other recent insider transactions involving Zymeworks Inc (ZYME) include a net purchase of 5,868,900 shares made by Ecor1 Capital, Llc , a net sale of 8,654 shares made by Christopher Astle , and a net sale of 23,904 shares made by Kenneth Galbraith .

In summary, during the past 3 months, insiders sold 0 shares of Zymeworks Inc (ZYME) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 52,759 shares of Zymeworks Inc (ZYME) were sold and 5,868,900 shares were bought by its insiders, resulting in a net purchase of 5,816,141 shares.

Zymeworks Inc (ZYME)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Zymeworks Inc Insider Transactions

No Available Data

Neil Josephson Mailing Address

Above is the net worth, insider trading, and ownership report for Neil Josephson. You might contact Neil Josephson via mailing address: 114 East 4th Avenue, Suite 800, Vancouver A1 V5t 1g4.

Discussions on Neil Josephson

No discussions yet.